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■ Abstract
Background: Several studies have suggested a relationship between asthma and obesity; however, this relationship is unclear when obesity 
is compared with bronchial hyperresponsiveness to methacholine. 
Aim: To determine whether obesity is associated with a diagnosis of asthma.
Methods: We conducted a cross-sectional study in a population of Spanish adults in the north of Madrid, Spain between 2003 and 
2007. The patients included had experienced asthma symptoms during the previous year, but had a ratio of forced expiratory volume in 
the fi rst second of expiration (FEV1) to forced vital capacity (FVC) of >70%. Diagnosis was confi rmed by the presence of symptoms and 
demonstration of bronchial hyperresponsiveness to methacholine. Obesity was measured by body mass index (BMI). Adjusted odd ratios 
(OR) were obtained by logistic regression. 
Results: Of a total of 1424 patients included, 251 (17.6%) were diagnosed with asthma. These patients were younger (P<.001) and had 
lower BMI (P<.001) and lung function parameters (FEV1 and FEV1/FVC ratio) than individuals without asthma (P<.001). After adjusting 
the model for age, gender, baseline FEV1, and FEV1/FVC ratio, patients with overweight or obesity were not more frequently diagnosed 
with asthma than those with normal weight (OR, 0.848 [95% confi dence interval (CI), 0.59-1.20]; and OR, 0.616 [95% CI, 0.38-0.99], 
respectively). In addition, obese males were more frequently diagnosed with asthma than obese females (P<.041).   
Conclusions: In this study, obesity and overweight were not associated with a diagnosis of asthma based on the presence of consistent 
symptoms and demonstration of airway responsiveness to methacholine.
Key words: Asthma. Obesity. Body mass index. Airway hyperresponsiveness.
■ Resumen
Fundamento: Varios estudios sugieren que la obesidad es un factor de riesgo para padecer asma, lo que no siempre se confi rma cuando 
se compara la obesidad con la hiperreactividad bronquial (HRB) en pacientes con síntomas de asma. 
Objetivo: Determinar si la obesidad se asocia con el diagnóstico de asma, confi rmado por presencia de síntomas e HRB a metacolina.
Pacientes y Métodos: Se realizó un estudio transversal en población adulta del Área Norte de Madrid entre 2003 y 2007. Se incluyeron 
sujetos que habían padecido síntomas de asma en el último año, con un FEV1/FVC>70% y que precisaban una prueba de metacolina 
para confi rmar el diagnóstico. La obesidad se defi nió según el índice de masa corporal (IMC). Se aplicó un modelo de regresión logística 
para calcular odd ratios (OR) ajustadas. 
Resultados: Se estudiaron 1.424 sujetos y se diagnosticaron de asma 251 sujetos (17,6%)  que, comparados con los 1.173 no  diagnosticados 
de asma,  eran más jóvenes y presentaban un IMC y  parámetros de función pulmonar (FEV1,  FEV1/FVC) más bajos (p<0,001). Tras ajustar 
el modelo por edad, sexo, FEV1 basal y FEV1/FVC el diagnóstico de asma no fue más prevalente en los sujetos obesos o con sobrepeso que 
en los sujetos con peso normal (OR 0,848, IC95% 0,59-1,20 y OR 0,616, IC95% 0,38-0,99, respectivamente). El diagnóstico de asma 
fue más frecuente en hombres obesos que en mujeres obesas (p=0,041).
Conclusiones: La obesidad y el sobrepeso no se asociaron con el diagnóstico de asma establecido por la presencia de síntomas e HRB a 
metacolina.  
Palabras clave: Asma. Obesidad. Índice de masa corporal. Hiperreactividad bronquial.
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Introduction
Asthma and obesity are common disorders with an 
enormous impact on public health. It has been estimated that 
up to 65% of the adult population of the United States of 
America is obese or overweight [1], while in Spain about 15% 
of the population is obese and 39% is overweight [2]. These 
fi gures have increased progressively in recent years. Although 
bronchial asthma affects a smaller proportion of people, 
its prevalence has also increased in the last few decades. 
According to the Centers for Disease Control and Prevention, 
the prevalence of asthma in North American children increased 
from 3.6% in 1980 to 5.8% in 2003 [3]. In Spain, the prevalence 
of asthma increased by 0.26% per year from 1991 to 2001 [4]. 
Epidemiological data have led some researchers to suggest 
that obesity is a risk factor for the development of new-onset 
asthma, with odds ratios (OR) of between 1.1 and 3.0–when 
comparing the highest body mass index (BMI) with the lowest 
BMI categories–and the effect is apparently stronger in women 
[5]. A meta-analysis investigating overweight and obesity as 
risk factors for incidental asthma showed that both conditions 
progressively increased the odds of incident asthma and that the 
strength of this relationship was similar in men and women [6]. 
The exact nature of this association has not been fully 
elucidated, and methodological issues such as determining who 
has asthma compared with who has symptoms that mimic asthma 
hamper many studies [3]. However, mechanical factors or aspects 
of systemic infl ammation related to obesity may contribute to 
the pathogenesis of asthma [2,7,8]. Simple obesity can cause 
an increase in airway resistance and a mild degree of airfl ow 
limitation [9]. Therefore, establishing a fi rm diagnosis of asthma 
in obese patients with or without airfl ow limitations would require 
confi rmation by an objective procedure, such as measurement 
of airway hyperresponsiveness. We report the results of a cross-
sectional study of a population of adults from the north of Madrid, 
Spain who were investigated for suspected asthma between 2003 
and 2007. The aim of this study was to determine whether obesity, 
measured by BMI, is associated with a diagnosis of asthma, as 
established by the presence of symptoms and demonstration of 
airway responsiveness to methacholine.
Methods
Study Population
Patients were consecutively recruited from outpatient 
asthma clinics at the Allergy and Pulmonology Departments 
of La Paz Hospital, Madrid between 2003 and 2007. All 
patients were adults who, according to their allergist or 
pulmonologist, had presented with symptoms suggestive of 
asthma (cough, shortness of breath, or wheezing) in the last 
year, with a ratio of forced expiratory volume in the fi rst second 
of expiration (FEV1) to forced vital capacity (FVC) of >70%, 
and in whom it was necessary to establish the diagnosis of 
asthma by measuring airway hyperresponsiveness (AHR) to 
methacholine. Patients with contraindications for methacholine 
challenge testing as outlined in the American Thoracic Society 
(ATS) guidelines [10] were excluded.
All patients gave their written informed consent, and 
the study was approved by the Ethics Subcommittee of the 
Research Committee of Hospital Universitario La Paz, Madrid, 
Spain (code: HULP:PI-619).
Variables 
The variables studied were age, gender, smoking status, 
height (m), weight (kg), BMI, and lung function (FVC, FEV1, 
and FEV1/FVC), which was measured immediately before the 
methacholine challenge test. The results of the methacholine 
challenge test were considered positive or negative.
Defi nitions
Asthma: Asthma was defi ned as a categorical dichotomous 
variable based on the presence of both consistent symptoms in the 
previous 12 months and a demonstration of AHR to methacholine. 
Obesity: The weight and height of each patient were 
measured in street clothes without shoes immediately before 
performing the methacholine challenge test. BMI (kg/m2) was 
calculated for each patient and categorized as follows: normal 
weight, BMI <25 kg/m2; overweight, BMI 25.0-29.9 kg/m2; 
and obese, BMI ≥30 kg/m2.
Spirometry and Methacholine Challenge Test 
Spirometry was performed according to ATS 
recommendations [11]. 
Methacholine challenge tests were performed in both 
departments of the hospital according to current guidelines 
[10], and the spirometric reference values used were those 
reported by the European Community of Coal and Steel 
and the European Respiratory Society in 1993 [12]. The 
methacholine challenge test was performed according to ATS 
recommendations following the 5-breath dosimeter protocol 
[10]. In the Allergy Department, testing was conducted using 
an electronic dosimeter (Spira Elektro, Respiratory Care 
Centre, Hameelinna, Finland), with an output of 0.45 μL 
and a nebulization time of 0.6 seconds, and the provocative 
concentration causing a 20% drop in FEV1 (PC20) was 
calculated. In the Pulmonology Department, testing was 
performed using a bronchial aerosol provocation system 
(APS, Jaeger, Würzburg, Germany), with a Medic-Aid 
SideStream nebulizer (Medic-Aid Ltd, Bognor Regis, UK), 
and the provocative dose causing a 20% drop in FEV1 (PD20) 
was calculated. This nebulizer was calibrated to produce an 
output of 160 mg/mL with an airfl ow rate of 100 mL/s. A fl ow 
sensor in the expiratory port triggers a solenoid that exposes the 
nebulizer to compressed air at 138 kPa for about 0.6 seconds 
to give a calibrated output per puff of 9.0 μL. The nebulizer 
generates heterodisperse droplets with a median aerodynamic 
mass diameter of 0.5 to 4 μm. AHR was considered positive or 
present if there was a ≥20% fall in FEV1 from baseline with a 
PD20 ≥2.0 mg (9.9 μmol) of methacholine [13] or PC20 (5-breath 
dosing) of ≤16 mg/mL of methacholine [10].
Statistical Analysis
Data are expressed as mean (SD) and percentages. 
Univariate relationships between dependent and independent 
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variables were explored using the t test. One-way analysis of 
variance was used to compare normally distributed variables, 
the Wilcoxon rank sum test for skewed variables, and the χ2 
test for categorical variables. Univariate and multivariate 
conditional logistic regression models were constructed 
to determine the odds of having asthma in different BMI 
categories after adjusting for the other variables. For all 
analyses, a 2-tailed P<.05 was considered signifi cant. All 
analyses were performed with the SAS statistical software 
package, version 9.1.3 (SAS Institute, Cary, North Carolina, 
USA).
Table 1. Baseline Characteristics
  
    
 No. Asthma Asthma Total P Value
  
Patients, n 1173 251 1424 
Age, y, mean (SD) 41.96 (16.94) 33.96 (14.67) 40.55 (16.83) <.001a
BMI, kg/m2, mean (SD) 26.27 (5.01) 24.48 (4.27) 25.96 (4.94) .001a 
Gender, n (%)    .549b
Male  364 (81.4) 83 (18.6) 447
Female 809 (82.8) 168 (17.2) 977
Smoking status, n (%)    .625b
Nonsmoker 810 (83.6) 159 (16.4) 969
Current smoker 184 (82.1) 40 (17.9) 224
Ex-smoker 139 (80.8) 33 (19.2) 172 
FVC, L, mean (SD)  3.800 (1.142) 4.229 (3.406) 3.875 (1.773) .156a
FEV1, L, mean (SD) 3.274 (.986) 3.321 (.850) 3.283 (.963) .440a 
FEV1, % predicted, mean (SD) 86.48 (9.66) 82.88 (11.16) 85.84 (10.03) <.001a 
FEV1/FVC, mean (SD) 0.867 (.115) 0.829 (.111) 0.860 (.112) <.001a 





We included 1424 patients, of whom 981 (86.9%) were 
from the Pulmonology Department and 443 (31.1%) were from 
the Allergy Department. Mean BMI was 25.96 kg/m2 (SD, 
4.94). Normal weight was recorded in 666 patients (46.7%), 
overweight in 481 (33.8%), and obesity in 277 (19.5%).
Asthma was diagnosed in 251 patients (17.6%). The results 
of a univariate analysis according to asthma diagnosis are 
shown in Table 1. Asthma patients were younger and had a 
Table 2. Association Between Body Mass Index and Asthma Diagnosis (Symptoms and Bronchial Hyperresponsiveness)
BMI category  Asthmaa No asthma Total OR Adjusted OR 
 No. (%) No. (%) No. (%) (95% CI) (95% CI)b
Normal weight, BMI<25 kg/m2 125 515 666
 (22.7%) (77.3%) (46.8%)                  
Overweight, BMI 25-29.9 kg/m2 72 409 481 0.6 0.848 
 (15%) (85%) (33.8%) (0.44-0.82) (0.59-1.20) 
Obese, BMI ≥30 kg/m2 28 249 277 0.3841 0.616
 (10.1%) (89.9%) (19.4%) (0.25-0.59) (0.38-0.99) 
All BMI categories 251 1173 1424               
 (17.6%) (82.4%) (100%)               
Abbreviations: BMI, body mass index; CI, confi dence interval; FEV1, forced expiratory volume in the fi rst second of expiration; FVC, 
forced vital capacity; OR, odds ratio; PC20, provocative concentration causing a 20% drop in FEV1; PD20, provocative dose causing a 
20% drop in FEV1.
aGeometric mean: PC20, 3.58 mg/mL; PD20, 0.77 mg.
bModel adjusted for age, sex, FEV1, and FEV1/FVC at baseline.
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lower BMI than those without asthma (P<.001). No signifi cant 
differences were observed in smoking status according to 
asthma diagnosis. Lung function spirometric parameters (FEV1 
as percent predicted and FEV1/FVC ratio) were signifi cantly 
lower in asthma patients than in those without asthma (Table 1).
Relation of Asthma to Body Mass Index
The distribution of patients with confi rmed asthma is 
shown in Table 2. After adjustment for age, gender, baseline 
FEV1, and FEV1/FVC ratio, patients with overweight or obesity 
Table 3. Gender Classifi ed According to Body Mass Index and Asthma
 BMI Category  Asthma No Asthma Total P Value
  No. (%) No. (%) No. (%)
  
Normal weight    .176a
Male 34 (18.9%) 146 (81.1%) 180 (27%)
Female 117 (24.1%) 369 (75.9%) 486 (73%)
Total 151 515 666
Overweight    .051
Male 37 (19%) 158 (81%) 195 (40.5%)
Female 35 (12.2%) 251 (87.8%) 286 (59.5%)
Total 72 409 481 
Obese    .041
Male 12 (17%) 60 (83%) 72 (26%)
Female 16 (7.8%) 189 (92.2%) 205 (74%)
Total 28 249 277
 
All patients 251 1173 1424  
aχ2 test. 
Table 4. Smoking Status Classifi ed According to Body Mass Index and Asthma
 BMI Category  Asthma No Asthma Total P Value
  No. (%) No. (%) No. (%)
  
Normal weight     .731a
Nonsmoker 99 (22.6) 340 (77.4) 439 (69.5)
Current smoker  26 (20.2) 103 (79.8) 129 (20.4)
Ex-smoker 16 (25) 48 (75) 64 (10.1)
Total 141 (22.3) 491 (77.7) 632   
Overweight    .700
Nonsmoker 42 (13.5) 270 (86.5) 312 (67.7)
Current smoker 10 (14.9) 57 (85.1) 67 (14.5) 
Ex-smoker 14 (17.1) 68 (82.9) 82 (17.8)
Total 66 (14.3) 395 (85.7) 461
Obese    .530
Nonsmoker 18 (8.3) 200 (91.7) 218 (80.1)
Current smoker 4 (14.3) 24 (85.7) 28 (10.3) 
Ex-smoker 3 (11.5%) 23 (88.5) 26 (9.6)
Total 25 (9.2) 247 (90.8) 272 
All patients 232 1133 1365  
aχ2 test. 
were not more frequently diagnosed with asthma than those 
with normal weight (OR, 0.848 [95% confi dence interval (CI), 
0.59-1.20]; and OR, 0.616 [95% CI, 0.38-0.99], respectively).
Effects of Other Variables 
A multivariate analysis of gender distribution (Table 3) 
for patients classifi ed according to BMI and asthma showed 
that obese males were more frequently diagnosed with asthma 
than obese females (P=.041). Smoking data (Table 4) revealed 
no signifi cant differences. Increasing BMI had no signifi cant 
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Table 5. FEV1, FEV1, and FEV1/FVC Data of Asthma Patients Classifi ed According to BMIa 
   Normal Weight Overweight Obese P Valueb
  No. (%) No. (%) No. (%)
  
FEV1, L 3.33 (0.791) 3.38 (0.100) 3.10 (0.719) .32   
FEV1, % predicted 83.7 (11) 81.01 (9.6) 83 (14.3) .23
FEV1/FVC 0.83 (0.11) 0.81 (0.96) 0.83 (14) .23 
Abbreviations: BMI, body mass index; FEV1, forced expiratory volume in the fi rst second of expiration; FVC, forced vital capacity.
aResults expressed as mean (SD). 
bAnalysis of variance.
effect on spirometric results (FEV1, FEV1/FVC ratio) in asthma 
patients (Table 5). 
Discussion
We found that obesity and overweight, defi ned as a BMI of 
≥30 kg/m2 and 25-29.9 kg/m2, respectively, were not associated 
with a higher prevalence of confi rmed asthma diagnosis in a 
population of adults from Madrid. Similar results were found 
in another Spanish study [14]. The distribution of BMI in this 
sample was similar to the distribution in the general population 
of Spain [2].
Although obesity has been associated with severe asthma 
[15], the results of the Severe Asthma Research Program [16], 
did not fi nd obesity to be more prevalent in severe asthma than 
in milder asthma; therefore, further studies are necessary in 
this area.
The population we describe had an FEV1/FVC ratio >70% 
and similar characteristics to those of the population reported 
in the main articles [17-19] on the association between excess 
weight and AHR in patients with symptoms of asthma.
In the European Community Respiratory Health Survey, 
AHR increased with BMI in men but not in women [17]. 
In a case-control study from participants in the Normative 
Aging Study, a high initial BMI was associated with the 
development of AHR to methacholine (OR, 10; 95% CI, 
2-6-37.9) when patients in the highest BMI quintile were 
compared with those in the middle quintile. There was also a 
linear relationship between increasing BMI during the study 
period and subsequent development of AHR [18].
In contrast, Schachter et al [19] showed that, in a group 
of 1971 adults, BMI was associated with asthma symptoms 
(dyspnea and wheezing) but not with airfl ow obstruction or 
AHR. Tantisira et al [20] showed similar results in a pediatric 
population.
Changes in anatomical and respiratory function could 
cause increased symptoms of cough, shortness of breath, 
and wheezing without altering airway behavior. Sutherland 
et al [21] studied 30 obese and nonobese adult women with 
asthma and observed that changes in respiratory function, 
especially dynamic hyperinfl ation, were more pronounced in 
obese individuals with bronchoconstriction; however, BMI 
was independently associated with changes in lung volume 
and AHR. In our study, no signifi cant effects of increasing 
BMI on spirometric results were observed in asthma patients. 
Salome et al [22] studied the effect on breathlessness and AHR 
to methacholine in 49 nonasthmatic patients (23 obese and 26 
nonobese) aged between 18 and 70 years. The authors found that 
obesity reduced lung volume, but did not alter the sensitivity of 
or maximal response to methacholine. However, obese patients 
had an enhanced perception of dyspnea–associated with greater 
apparent stiffness of the respiratory system–and may therefore 
be at greater risk of symptoms. Similar results were encountered 
by Machado et al [23]. In addition, simulated obesity-related 
changes in lung volume increased airway responsiveness in 
lean nonasthmatic patients [24].
Some prospective studies have suggested that the 
relationship between obesity and asthma is stronger in women 
[25]; however, the difference in estimates of effect between 
men and women is usually small. In a random-effects meta-
analysis of data from 7 studies, a similar increase in the odds 
of incident asthma due to overweight and obesity was observed 
in men (OR, 1.46; 95% CI, 1.05-2.02) and women (OR, 1.68; 
95% CI, 1.45-1-94) [6]. In the present study, a diagnosis of 
asthma was more common in obese men than obese women 
classifi ed according to BMI.
The cause of bronchial infl ammation in obese patients with 
asthma appears to be different from that of atopy [8,24]. It is 
now well established that obesity is characterized by a state 
of chronic low-grade systemic infl ammation. Adipose tissue 
secretes important regulatory adipokines such as leptin, a 
proinfl ammatory adipokine, and adiponectin, which has anti-
infl ammatory properties [8]. It has been suggested that leptin 
may contribute to the increased prevalence of asthma observed 
among obese persons [8]; however, recent studies indicate that 
the association between obesity and asthma is unlikely to be 
due to a direct effect of leptin on airway smooth muscle [26]. 
In the present study, a diagnosis of asthma was confi rmed 
in 17.6% of patients based on symptoms of cough, shortness of 
breath, or wheezing. Aaron et al [27] found that about one-third 
of obese and nonobese individuals with physician-diagnosed 
asthma did not have asthma when objectively assessed. 
Therefore, asthma may be overdiagnosed in developed countries. 
Moreover, if symptoms in this group are due to causes unrelated 
to asthma, then asthma medication would be unlikely to affect 
their symptoms. In fact, symptoms alone do not appear to be a 
good guide for the diagnosis and treatment of asthma. 
In conclusion, although our study is subject to the 
limitations of cross-sectional studies, obesity was not 
associated with asthma in a population of adults from the 
north of Madrid. 
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